HemaCare Corporation, founded in 1978, customizes blood management programs for health care facilities and provides blood products and services to over 80 hospitals in Southern California. It is publicly held, licensed by the State of California for Biologics and the Food and Drug Administration (FDA). The Company is also accredited by the American Association of Blood Banks (AABB).
Profitable company, with earnings expected to increase with the improved practices of the ARC.
For the short term:
Notice in the last press release regarding the delisting threat and I quote:
" The company is presently assessing the options available to achieve compliance with the rule and INTENDS TO RETAIN ITS NASDAQ LISTING. "
To do so they need the price of the stock to exceed $1 for a minimum of 10 days. This is from a healthy and profitable company with a lot of cash???
They have three options:
1- reverse split: probably is too late for this option.
2- big anouncements under thier sleeves: maybe.
3- A buy back of shares: most likely.
Therefore we are sure to see the dollar and more. Exact same scenario with BITI which was also threatend by delisting and they promissed to do some thing about it. Study BITI carefully and you will see the similarities, infact HEMA has even better financial numbers. BITI is expected to get another jump start really soon to stay above the $1. Though HEMA in the long run is sure to be at the $5 range because of the impressive numbers, soon it will jump %100 and more to stay NASDAQ.
Insiders are holding tight on shares that are valued at a $1.5 which is more than 2x where we are now.
In my humble view, a sure winner.
Homepage: hemacare.com |
